Agios Pharma's total assets for Q1 2026 were $1.18B, a decrease of -8.65% from the previous quarter. AGIO total liabilities were $75.88M for the fiscal quarter, a -27.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.